Robotic Surgery Services Global Market Report 2021: COVID 19 Growth And Change to 2030

Major players in the robotic surgery services market are Intuitive Surgical Inc, Stryker Corporation, Medrobotics Corporation, Johnson & Johnson, Globus medicals, NuVasive, Smith & Nephew plc, Titan Medical Inc, TransEnterix Inc and University of Pittsburgh Medical Centre.

New York, May 07, 2021 (GLOBE NEWSWIRE) — announces the release of the report “Robotic Surgery Services Global Market Report 2021: COVID 19 Growth And Change to 2030” –

The global robotic surgery services market is expected grow from $0.57 billion in 2020 to $0.75 billion in 2021 at a compound annual growth rate (CAGR) of 31.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1.49 billion in 2025 at a CAGR of 19%.

The robotic surgery services market consists of the sale of services provided Robotic surgical technology, the highly advanced technological form of non-invasive surgery that utilizes robots and computer systems to conduct surgeries with lesser incision and more precision. The commonly used robotic surgical system consists of a mechanical arm and camera arm attached to surgical instruments with a controlled by a surgeon being seated at a computer console which is usually in the same room as the surgical table, or can be around the world.

Increase in purchasing power of hospitals and ambulatory care services has helped in the growth of the robotic surgery service market.Hospitals and ambulatory care services are interested in buying latest technologies to provide advanced care to the patients as well as to achieve an edge over their competitors.

According to the fourth quarter financial results 2019 of intuitive Surgical, the robotic surgical giant, the company has shipped around 336 DA Vinci systems during the quarter when compared to 290 during the fourth quarter of 2018.It has almost 5,582 DA Vinci systems installed, with a 12% year-over-year increase.

According to the 2019 Annual Report of Intuitive Surgical, Inc., the number of DA Vinci procedures worldwide has risen by approximately 18%. The need for more minimally invasive surgery by growing geriatric population coupled with the prevalence of chronic disease such as diabetes, HIV/AIDS, asthma, arthritis, and other diseases has increased the demand for robotic surgery services. According to the World Health Organization (who) report, there will be a 57 % increase in chronic illness. Therefore, the purchasing power of hospital and ambulatory care services coupled with the increase in the geriatric population and prevalence of chronic illness have contributed to the growth of robotic surgery services market.

Safety concerns regarding the use of robotic surgery services are likely to cause a hindrance to the robotic surgery services market.The FDA Safety communication raised a concern in February 2019 about using robotic surgery for mastectomy procedures or for the prevention or treatment of cancer as the effectiveness and safety of these devices is not established.

According to the survey of New England journal of medicine, the survival rate of patients having minimally invasive surgery compared to patients having open surgery is lower.Over the past two decades more than 8,061 device malfunctions, 1,391 injuries, and 144 deaths occurred in robotic surgery service.

Due to such concerns more products have been recalled from the market. On September 2019 Zimmer Biomet has recalled its ROSA brain 3.0 robotic surgery system because of a software problem which can drive the robotic arm to an incorrect position which can risk patient’s life. This was identified as a class 1 recall which is the most serious kind of classification by the FDA. These safety concerns lead to more stringent regulations by the regulatory agencies like the FDA, which would in turn increase the cost and time period for the research and development activities. Therefore, the safety issues pertaining to robotic surgeries leading to product recalls is expected to hinder the growth of the robotic surgery services market.

The robotic surgery services market covered in this report is segmented by application into general surgery; urological surgery; gynaecological surgery; orthopaedic surgery; neurosurgery; other applications and by end-users: hospitals; ambulatory surgery centres (ASCS).

Image guide navigation system combined with the robotic surgery system offers more possibility to visualize and perform the minimally invasive surgery in areas which were earlier difficult, especially the orthopaedic surgeries and neurosurgeries.The Mazor X Stealth system by Medtronic, and the NuVasive’s Pulse and Excelsius GPS by Globus Medical, among others use image guided navigation system to perform spine surgeries, and orthopaedic implant surgeries such as total, partial knee and hip replacements as they provide the surgeon with 3D experience.

The image-guided navigation reduces the radiation effects and patients do not require to take an X ray after the procedure. These factors state that the image guided navigation system is expected to be a trend in robotic surgery services.

On October 2019 Corindus Vascular Robotics Inc., a leading developer of precision vascular robotics was acquired by Siemens Healthineers AG, a German conglomerate of medical technology offering wide range of products in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine for an amount of USD 1.1 billion the main aim of this acquisition is to optimize the procedures and to increase the clinical outcomes by collaborating each other’s technologies, it also opens a new market for Siemens.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


Contact Data

US: (339)-368-6001
Intl: +1 339-368-6001

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button